Mechanisms of chronic JAK-STAT3-SOCS3 signaling in obesity.

PubWeight™: 1.04‹?› | Rank: Top 15%

🔗 View Article (PMC 3710326)

Published in JAKSTAT on April 01, 2013

Authors

Claudia M Wunderlich1, Nadine Hövelmeyer, F Thomas Wunderlich

Author Affiliations

1: Max Planck Institute for Neurological Research; Institute for Genetics; University of Cologne and Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD) and Center of Molecular Medicine Cologne (CMMC); Cologne, Germany.

Articles citing this

Elevated peripheral frequencies of Th22 cells: a novel potent participant in obesity and type 2 diabetes. PLoS One (2014) 1.03

Toward a new STATe: the role of STATs in mitochondrial function. Semin Immunol (2014) 0.95

Chronic sleep fragmentation during the sleep period induces hypothalamic endoplasmic reticulum stress and PTP1b-mediated leptin resistance in male mice. Sleep (2015) 0.91

Activation of G proteins by GIV-GEF is a pivot point for insulin resistance and sensitivity. Mol Biol Cell (2015) 0.83

Knockout of STAT3 in skeletal muscle does not prevent high-fat diet-induced insulin resistance. Mol Metab (2015) 0.83

Macrophage function in obesity-induced inflammation and insulin resistance. Pflugers Arch (2017) 0.78

IL-6 mediates differentiation disorder during spermatogenesis in obesity-associated inflammation by affecting the expression of Zfp637 through the SOCS3/STAT3 pathway. Sci Rep (2016) 0.78

Epistatic effects on abdominal fat content in chickens: results from a genome-wide SNP-SNP interaction analysis. PLoS One (2013) 0.77

Leucine supplementation improves leptin sensitivity in high-fat diet fed rats. Food Nutr Res (2015) 0.76

IL-15 Activates the Jak3/STAT3 Signaling Pathway to Mediate Glucose Uptake in Skeletal Muscle Cells. Front Physiol (2016) 0.76

Proteomic Analysis, Immune Dysregulation and Pathway Interconnections with Obesity. J Proteome Res (2016) 0.75

Inter-Tissue Gene Co-Expression Networks between Metabolically Healthy and Unhealthy Obese Individuals. PLoS One (2016) 0.75

Inflammatory Cytokines and BDNF Response to High-Intensity Intermittent Exercise: Effect the Exercise Volume. Front Physiol (2016) 0.75

CNTF Attenuates Vasoproliferative Changes Through Upregulation of SOCS3 in a Mouse-Model of Oxygen-Induced Retinopathy. Invest Ophthalmol Vis Sci (2016) 0.75

Adenosine A₁ receptors in mouse pontine reticular formation modulate nociception only in the presence of systemic leptin. Neuroscience (2014) 0.75

AMPK Suppresses Vascular Inflammation In Vivo by Inhibiting Signal Transducer and Activator of Transcription-1. Diabetes (2015) 0.75

Weight Perturbation Alters Leptin Signal Transduction in a Region-Specific Manner throughout the Brain. PLoS One (2017) 0.75

Role of Leptin and SOCS3 in Inhibiting the Type I Interferon Response During Obesity. Inflammation (2016) 0.75

Withania somnifera as a potential candidate to ameliorate high fat diet-induced anxiety and neuroinflammation. J Neuroinflammation (2017) 0.75

Aging and calorie restriction regulate the expression of miR-125a-5p and its target genes Stat3, Casp2 and Stard13. Aging (Albany NY) (2017) 0.75

Articles cited by this

Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest (2003) 41.22

Inflammation, stress, and diabetes. J Clin Invest (2005) 17.11

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA (2001) 15.85

Leptin and the regulation of body weight in mammals. Nature (1998) 14.84

Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science (1994) 11.33

Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J (2003) 10.77

Obesity and insulin resistance. J Clin Invest (2000) 10.47

A family of cytokine-inducible inhibitors of signalling. Nature (1997) 9.22

Leptin receptor signaling in POMC neurons is required for normal body weight homeostasis. Neuron (2004) 7.15

Hypothalamic IKKbeta/NF-kappaB and ER stress link overnutrition to energy imbalance and obesity. Cell (2008) 6.83

A single phosphotyrosine residue of Stat91 required for gene activation by interferon-gamma. Science (1993) 6.44

STATs: signal transducers and activators of transcription. Cell (1996) 6.10

Leptin receptor signaling in midbrain dopamine neurons regulates feeding. Neuron (2006) 5.64

Proteins of transcription factor ISGF-3: one gene encodes the 91-and 84-kDa ISGF-3 proteins that are activated by interferon alpha. Proc Natl Acad Sci U S A (1992) 5.50

A stress signaling pathway in adipose tissue regulates hepatic insulin resistance. Science (2008) 5.28

Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat Rev Endocrinol (2012) 4.87

SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2. J Biol Chem (2002) 4.84

An interleukin-4-induced transcription factor: IL-4 Stat. Science (1994) 4.71

Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes (2004) 4.67

Interleukin-6-deficient mice develop mature-onset obesity. Nat Med (2002) 4.47

Twenty proteins containing a C-terminal SOCS box form five structural classes. Proc Natl Acad Sci U S A (1998) 4.38

Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes (2007) 4.28

Jaks and Stats in signaling by the cytokine receptor superfamily. Trends Genet (1995) 4.19

Identification of SOCS-3 as a potential mediator of central leptin resistance. Mol Cell (1998) 3.84

Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms. Mol Cell Biol (2004) 3.79

The leptin receptor. J Biol Chem (1997) 3.76

The proteins of ISGF-3, the interferon alpha-induced transcriptional activator, define a gene family involved in signal transduction. Proc Natl Acad Sci U S A (1992) 3.74

Interferon-alpha regulates nuclear translocation and DNA-binding affinity of ISGF3, a multimeric transcriptional activator. Genes Dev (1990) 3.65

MyD88 signaling in the CNS is required for development of fatty acid-induced leptin resistance and diet-induced obesity. Cell Metab (2009) 3.64

PTP1B regulates leptin signal transduction in vivo. Dev Cell (2002) 3.61

Janus kinases in immune cell signaling. Immunol Rev (2009) 3.60

Identification of a nuclear Stat1 protein tyrosine phosphatase. Mol Cell Biol (2002) 3.57

Activation of downstream signals by the long form of the leptin receptor. J Biol Chem (2000) 3.52

SOCS proteins: negative regulators of cytokine signaling. Stem Cells (2001) 3.40

Involvement of the Jak-3 Janus kinase in signalling by interleukins 2 and 4 in lymphoid and myeloid cells. Nature (1994) 3.36

Role of hepatic STAT3 in brain-insulin action on hepatic glucose production. Cell Metab (2006) 3.34

Cytokine signaling through nonreceptor protein tyrosine kinases. Science (1995) 3.16

Two putative protein-tyrosine kinases identified by application of the polymerase chain reaction. Proc Natl Acad Sci U S A (1989) 3.14

Enhanced leptin sensitivity and attenuation of diet-induced obesity in mice with haploinsufficiency of Socs3. Nat Med (2004) 2.98

Inflammatory pathways and insulin action. Int J Obes Relat Metab Disord (2003) 2.94

Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J Clin Endocrinol Metab (2000) 2.88

Adipose tissue as an endocrine and paracrine organ. Int J Obes Relat Metab Disord (1998) 2.81

Extracellular signal-dependent nuclear import of Stat1 is mediated by nuclear pore-targeting complex formation with NPI-1, but not Rch1. EMBO J (1997) 2.80

Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes. J Biol Chem (2003) 2.67

Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse. Proc Natl Acad Sci U S A (2004) 2.54

Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1. Proc Natl Acad Sci U S A (1998) 2.48

Two novel protein-tyrosine kinases, each with a second phosphotransferase-related catalytic domain, define a new class of protein kinase. Mol Cell Biol (1991) 2.47

SOCS3 is essential in the regulation of fetal liver erythropoiesis. Cell (1999) 2.19

Suppressor of cytokine signaling 3 is a physiological regulator of adipocyte insulin signaling. J Biol Chem (2004) 2.11

Placental defects and embryonic lethality in mice lacking suppressor of cytokine signaling 3. Proc Natl Acad Sci U S A (2001) 2.09

Obesity, inflammation, and liver cancer. J Hepatol (2011) 2.09

Stat4, a novel gamma interferon activation site-binding protein expressed in early myeloid differentiation. Mol Cell Biol (1994) 1.98

tyk2, prototype of a novel class of non-receptor tyrosine kinase genes. Oncogene (1990) 1.95

Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. Obes Res (2001) 1.89

JAK2, a third member of the JAK family of protein tyrosine kinases. Oncogene (1992) 1.88

Arginine/lysine-rich nuclear localization signals mediate interactions between dimeric STATs and importin alpha 5. J Biol Chem (2002) 1.86

CNS leptin and insulin action in the control of energy homeostasis. Ann N Y Acad Sci (2010) 1.81

Chronic interleukin-6 (IL-6) treatment increased IL-6 secretion and induced insulin resistance in adipocyte: prevention by rosiglitazone. Biochem Biophys Res Commun (2003) 1.79

Interleukin-6 and its receptor: from bench to bedside. Med Microbiol Immunol (2006) 1.65

The melanocortin receptors: lessons from knockout models. Neuropeptides (2002) 1.61

Regulation of Jak kinases by intracellular leptin receptor sequences. J Biol Chem (2002) 1.57

Interleukin-6 signaling in liver-parenchymal cells suppresses hepatic inflammation and improves systemic insulin action. Cell Metab (2010) 1.49

Activation of Stat3 signaling in AgRP neurons promotes locomotor activity. Cell Metab (2008) 1.49

Regulation of cytokine signaling pathways by PIAS proteins. Cell Res (2006) 1.42

Interleukin 2 and erythropoietin activate STAT5/MGF via distinct pathways. EMBO J (1995) 1.42

Raised interleukin-6 levels in obese patients. Obes Res (2000) 1.39

Leptin receptor (OB-R) signaling. Cytoplasmic domain mutational analysis and evidence for receptor homo-oligomerization. J Biol Chem (1997) 1.38

Rac1 and a GTPase-activating protein, MgcRacGAP, are required for nuclear translocation of STAT transcription factors. J Cell Biol (2006) 1.36

Lipid and carbohydrate metabolism in mice with a targeted mutation in the IL-6 gene: absence of development of age-related obesity. Am J Physiol Endocrinol Metab (2004) 1.36

Enhanced Stat3 activation in POMC neurons provokes negative feedback inhibition of leptin and insulin signaling in obesity. J Neurosci (2009) 1.32

Overexpression of suppressor of cytokine signaling 3 in adipose tissue causes local but not systemic insulin resistance. Diabetes (2006) 1.30

Leptin receptor action in hepatic cells. J Biol Chem (1997) 1.29

Pharmacological preconditioning with tumor necrosis factor-alpha activates signal transducer and activator of transcription-3 at reperfusion without involving classic prosurvival kinases (Akt and extracellular signal-regulated kinase). Circulation (2005) 1.29

Biology and significance of the JAK/STAT signalling pathways. Growth Factors (2012) 1.29

The dual function of hepatic SOCS3 in insulin resistance in vivo. Genes Cells (2007) 1.28

Interleukin-6 and insulin resistance. Vitam Horm (2009) 1.27

Selective insulin and leptin resistance in metabolic disorders. Cell Metab (2012) 1.25

Leptin regulates glutamate and glucose transporters in hypothalamic astrocytes. J Clin Invest (2012) 1.21

Deletion of skeletal muscle SOCS3 prevents insulin resistance in obesity. Diabetes (2012) 1.20

Hepatic Bax inhibitor-1 inhibits IRE1alpha and protects from obesity-associated insulin resistance and glucose intolerance. J Biol Chem (2009) 1.20

JAK3: a novel JAK kinase associated with terminal differentiation of hematopoietic cells. Oncogene (1994) 1.16

A Rac GTPase-activating protein, MgcRacGAP, is a nuclear localizing signal-containing nuclear chaperone in the activation of STAT transcription factors. Mol Cell Biol (2009) 1.12

Interleukin-3, granulocyte-macrophage colony-stimulating factor, and interleukin-5 transduce signals through two forms of STAT5. J Leukoc Biol (1995) 1.12

Liver-specific suppressor of cytokine signaling-3 deletion in mice enhances hepatic insulin sensitivity and lipogenesis resulting in fatty liver and obesity. Hepatology (2010) 1.10

The suppressors of cytokine signalling (SOCS). Cell Mol Life Sci (2001) 1.06

Fine structure of the murine leptin receptor gene: splice site suppression is required to form two alternatively spliced transcripts. Genomics (1997) 1.05

Insulin resistance-inducing cytokines differentially regulate SOCS mRNA expression via growth factor- and Jak/Stat-signaling pathways in 3T3-L1 adipocytes. J Endocrinol (2004) 1.05

Leptin-induced cardioprotection involves JAK/STAT signaling that may be linked to the mitochondrial permeability transition pore. Am J Physiol Heart Circ Physiol (2010) 1.03

Leptin-signaling pathways and leptin resistance. Forum Nutr (2009) 1.02

Regulation of insulin and leptin signaling by muscle suppressor of cytokine signaling 3 (SOCS3). PLoS One (2012) 0.96

Reduced Socs3 expression in adipose tissue protects female mice against obesity-induced insulin resistance. Diabetologia (2012) 0.94

Cutting edge: Inhibition of IL-6 trans-signaling protects from malaria-induced lethality in mice. J Immunol (2012) 0.89

Interleukin-6 receptor α is co-localised with melanin-concentrating hormone in human and mouse hypothalamus. J Neuroendocrinol (2012) 0.86

Constitutive expression of suppressor of cytokine signalling-3 in skeletal muscle leads to reduced mobility and overweight in mice. Diabetologia (2009) 0.84

Protein kinases in human breast cancer. Breast Cancer Res Treat (1995) 0.84

Real-time PCR array to study effects of chemicals on the Hypothalamic-Pituitary-Gonadal axis of the Japanese medaka. Aquat Toxicol (2008) 0.82

Time-dependent transcriptional profiles of genes of the hypothalamic-pituitary-gonadal axis in medaka (Oryzias latipes) exposed to fadrozole and 17beta-trenbolone. Environ Toxicol Chem (2008) 0.77

Articles by these authors

A Cre-inducible diphtheria toxin receptor mediates cell lineage ablation after toxin administration. Nat Methods (2005) 5.59

Experimental autoimmune encephalomyelitis repressed by microglial paralysis. Nat Med (2005) 4.42

MyD88 signaling in the CNS is required for development of fatty acid-induced leptin resistance and diet-induced obesity. Cell Metab (2009) 3.64

Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation. Immunity (2011) 3.40

Prohibitins control cell proliferation and apoptosis by regulating OPA1-dependent cristae morphogenesis in mitochondria. Genes Dev (2008) 2.76

Obesity-induced overexpression of miRNA-143 inhibits insulin-stimulated AKT activation and impairs glucose metabolism. Nat Cell Biol (2011) 2.38

Hes1 is a critical but context-dependent mediator of canonical Notch signaling in lymphocyte development and transformation. Immunity (2010) 2.29

Central insulin action regulates peripheral glucose and fat metabolism in mice. J Clin Invest (2008) 2.00

Hypothalamic and pituitary c-Jun N-terminal kinase 1 signaling coordinately regulates glucose metabolism. Proc Natl Acad Sci U S A (2010) 1.67

PDK1 deficiency in POMC-expressing cells reveals FOXO1-dependent and -independent pathways in control of energy homeostasis and stress response. Cell Metab (2008) 1.63

Liver specific deletion of CYLDexon7/8 induces severe biliary damage, fibrosis and increases hepatocarcinogenesis in mice. J Hepatol (2012) 1.52

Expression of an activating mutation in the gene encoding the KATP channel subunit Kir6.2 in mouse pancreatic beta cells recapitulates neonatal diabetes. J Clin Invest (2008) 1.50

Activation of Stat3 signaling in AgRP neurons promotes locomotor activity. Cell Metab (2008) 1.49

Enhanced leptin-stimulated Pi3k activation in the CNS promotes white adipose tissue transdifferentiation. Cell Metab (2007) 1.39

Secondary consequences of beta cell inexcitability: identification and prevention in a murine model of K(ATP)-induced neonatal diabetes mellitus. Cell Metab (2009) 1.36

Enhanced Stat3 activation in POMC neurons provokes negative feedback inhibition of leptin and insulin signaling in obesity. J Neurosci (2009) 1.32

Site-specific recombination in human embryonic stem cells induced by cell-permeant Cre recombinase. Nat Methods (2006) 1.25

Tolerance without clonal expansion: self-antigen-expressing B cells program self-reactive T cells for future deletion. J Immunol (2008) 1.15

Loss of Roquin induces early death and immune deregulation but not autoimmunity. J Exp Med (2011) 1.11

Epidermal insulin/IGF-1 signalling control interfollicular morphogenesis and proliferative potential through Rac activation. EMBO J (2008) 1.09

Regulation of B cell homeostasis and activation by the tumor suppressor gene CYLD. J Exp Med (2007) 1.07

Contraction-induced interleukin-6 gene transcription in skeletal muscle is regulated by c-Jun terminal kinase/activator protein-1. J Biol Chem (2012) 1.01

VKORC1 deficiency in mice causes early postnatal lethality due to severe bleeding. Thromb Haemost (2009) 0.98

Insulin receptor signaling mediates APP processing and β-amyloid accumulation without altering survival in a transgenic mouse model of Alzheimer's disease. Age (Dordr) (2011) 0.95

Down-regulation of CYLD as a trigger for NF-κB activation and a mechanism of apoptotic resistance in hepatocellular carcinoma cells. Int J Oncol (2011) 0.94

Excision of the Frt-flanked neo (R) cassette from the CD19cre knock-in transgene reduces Cre-mediated recombination. Transgenic Res (2007) 0.91

Smad7 in T cells drives T helper 1 responses in multiple sclerosis and experimental autoimmune encephalomyelitis. Brain (2010) 0.91

Ablation of cyclase-associated protein 2 (CAP2) leads to cardiomyopathy. Cell Mol Life Sci (2012) 0.91

Cutting edge: Inhibition of IL-6 trans-signaling protects from malaria-induced lethality in mice. J Immunol (2012) 0.89

Alteration of JNK-1 signaling in skeletal muscle fails to affect glucose homeostasis and obesity-associated insulin resistance in mice. PLoS One (2013) 0.83

Naturally occurring short splice variant of CYLD positively regulates dendritic cell function. Blood (2009) 0.83

The tumor suppressor CYLD controls the function of murine regulatory T cells. J Immunol (2012) 0.81

The lack of annexin A7 affects functions of primary astrocytes. Exp Cell Res (2003) 0.80

K(ATP)-channel-dependent regulation of catecholaminergic neurons controls BAT sympathetic nerve activity and energy homeostasis. Cell Metab (2013) 0.78

Isolation of T cells from the gut. Methods Mol Biol (2014) 0.78

Obesity promotes liver carcinogenesis via Mcl-1 stabilization independent of IL-6Rα signaling. Cell Rep (2013) 0.77

Mutated cylindromatosis gene affects the functional state of dendritic cells. Eur J Immunol (2010) 0.77

Corrigendum: Efficient genome engineering by targeted homologous recombination in mouse embryos using transcription activator-like effector nucleases. Nat Commun (2015) 0.75